Initial Keytruda showed consistent antitumor activity and safety in patients with advanced bladder cancer ineligible for ...

From the deaths of actor Paul Teal and Chicago Bulls player Bob Love to a contestant on “Jeopardy!” revealing his colon cancer diagnosis, here’s what’s happening in the oncology space this week.

177Lu-PSMA-I&T therapy improved radiographic progression-free survival in metastatic castration-resistant prostate cancer ...

Magrolimab plus docetaxel improved outcomes in metastatic NSCLC patients with high CD47 expression, showing a median PFS of 8.9 months versus 2.6 months for lower expression. The ELEVATELung&UC trial ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated ...

With Thanksgiving coming soon, I find that November is the perfect time to reflect and gather feelings of gratitude as a ...

Aerobic exercise improved self-reported cognitive function in women undergoing chemotherapy for breast cancer but had no ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract ...

Focal Therapy May Reduce Side Effects, Improve Quality of Life in Prostate Cancer ...

Focal Therapy May Reduce Side Effects, Improve Quality of Life in Prostate Cancer ...

Patients with relapsed or refractory MDS may experience improved overall survival with , depending on certain prognostic ...